---
title: "INSILICO Plans Share Buyback of Up to HKD500M"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/303654455.md"
description: "INSILICO +0.400 (+1.092%) Short selling $33.75M; Ratio 13.729% announced that the Company has decided to repurchase shares of the Company in the open market on The Stock Exchange of Hong Kong Limited from time to time for an aggregate amount of up to HKD500 million pursuant to the general mandate granted to the Directors and approved by the shareholders of the Company. (HK stocks quote is delayed for at least 15 mins.Short Selling Data as at 2026-10-29 16:25.)"
datetime: "2026-10-30T01:18:42.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/303654455.md)
  - [en](https://longbridge.com/en/news/303654455.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/303654455.md)
generator: "portal-rs"
---

# INSILICO Plans Share Buyback of Up to HKD500M

INSILICO (03696.HK) +0.400 (+1.092%) Short selling $33.75M; Ratio 13.729% announced that the Company has decided to repurchase shares of the Company in the open market on The Stock Exchange of Hong Kong Limited from time to time for an aggregate amount of up to HKD500 million pursuant to the general mandate granted to the Directors and approved by the shareholders of the Company.  
(HK stocks quote is delayed for at least 15 mins.Short Selling Data as at 2026-10-29 16:25.)

### Related Stocks

- [03696.HK](https://longbridge.com/en/quote/03696.HK.md)

## Related News & Research

- [Insilico Medicine Subsidiary Partners With Luoxin Pharmaceuticals on AI-Powered Drug Discovery](https://longbridge.com/en/news/305433887.md)
- [Insilico Medicine Reports 40% Response Rate at 130 mg for ISM6331 in Phase 1 Mesothelioma Trial](https://longbridge.com/en/news/303086760.md)
- [Tesla Cybercab’s ‘Autonomy Subscription’ covers all bases for a self-driving car](https://longbridge.com/en/news/306297563.md)
- [Chainfir Capital says AI drug deal headlines mask reliance on uncertain milestone payments](https://longbridge.com/en/news/302495363.md)
- [Insilica und ProtoQSAR integrieren ProtoPRED® in ToxIndex, um die Bewertung der Chemikaliensicherheit voranzutreiben](https://longbridge.com/en/news/302778058.md)

---
> **Disclaimer: This article is for reference only and does not constitute any investment advice.**